Company: DAI – Fleming Fund

DAI – Fleming Fund is a renowned initiative operating in Pakistan, aimed at enhancing antimicrobial resistance (AMR) surveillance. With a focus on strengthening healthcare systems, DAI collaborates with local governments and institutions to improve data collection and analysis related to AMR. The initiative not only aims to ensure better health outcomes but also promotes responsible use of antibiotics. By fostering partnerships, DAI – Fleming Fund plays a crucial role in protecting public health and supporting sustainable healthcare practices in the country.